Piper Jaffray Downgrades Vascular Solutions (VASC) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Jefferies Raises Price Target on Teleflex (TFX) Ahead of Vascular Solutions (VASC) Acquisition
December 5, 2016 8:05 AM ESTJefferies reiterated a Hold rating on Teleflex (NYSE: TFX), and raised the price target to $155.00 (from $154.00) ahead of the company's acquisition of Vascular Solutions (NASDAQ: VASC) for $56 per share. Vascular Solutions will be both growth and margin accretive... More
Teleflex (TFX) to Acquire Vascular Solutions (VASC) in $1B Deal
December 2, 2016 6:47 AM ESTVascular Solutions, Inc. (Nasdaq: VASC) announced that it has entered into a definitive agreement to be acquired by Teleflex Incorporated (NYSE: TFX) for a purchase price of $56.00 per share in cash. The transaction implies an equity purchase price of $1.0 billion. Upon completion of the transaction, Vascular Solutions will become a wholly owned subsidiary of Teleflex.
The purchase price represents a 16% premium over Vascular Solutions average closing price during the 90 trading days ended December 1, 2016. In addition, the purchase price is 38.4x the midpoint of the companys preliminary 2017... More
